Related Experiment Video
Updated: Jan 4, 2026
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management
Anna Di Sessa1, Grazia Cirillo1, Stefano Guarino1
1Department of Woman, Child and General and Specialized Surgery, University of Studies of Campania "Luigi Vanvitelli", Napoli 80138, Italy.
Insights
Non-alcoholic fatty liver disease (NAFLD) is a growing childhood health concern linked to obesity. Research explores new diagnostic tools and treatments targeting metabolic pathways for better pediatric NAFLD management.
Area of Science:
- Pediatric Hepatology
- Metabolic Disorders
- Gastroenterology
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children.
- Obesity and metabolic syndrome are key drivers of pediatric NAFLD, contributing to a significant cardiometabolic burden.
- Current diagnostic methods rely on lab tests and imaging, with limited noninvasive alternatives.
Purpose of the Study:
- To review recent advancements in the diagnosis and treatment of pediatric NAFLD.
- To highlight emerging therapeutic strategies targeting NAFLD pathogenesis in children.
- To discuss future research directions for managing childhood NAFLD.
Main Methods:
- Literature review of recent studies on pediatric NAFLD diagnosis and treatment.
- Analysis of the "multiple-hit" hypothesis in NAFLD pathogenesis.
- Exploration of novel noninvasive diagnostic techniques and therapeutic targets.
Main Results:
- Lifestyle modifications, the current standard treatment, show limited efficacy due to poor compliance.
- Promising results are emerging from research into treatments targeting insulin resistance, dyslipidemia, gut-liver axis, oxidative stress, and inflammation.
- Innovative therapeutic approaches are being investigated to complement existing knowledge.
Conclusions:
- Pediatric NAFLD is a significant health issue requiring improved management strategies.
- Novel diagnostic and therapeutic interventions show promise but need further validation.
- Future research should focus on innovative treatments and comprehensive management of pediatric NAFLD.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) represents the most common cause of chronic liver disease in childhood. To date, the "multiple-hit" hypothesis is largely recognized as an explanation of NAFLD pathogenesis and progression. Obesity and features of the metabolic syndrome have been closely linked to NAFLD development. Due to the increased prevalence of obesity worldwide, NAFLD has reached epidemic proportions over time. Given its unfavorable cardiometabolic burden (such as cardiovascular and metabolic consequences), it represents a worrying phenomenon needing a more comprehensive and successful management. Laboratory tests and classical imaging techniques play a pivotal role in NAFLD diagnosis, but novel noninvasive alternative methods to diagnose and monitor NAFLD have been investigated. Currently, lifestyle modifications remain the mainstay treatment, although its efficacy is poor because of the lack of compliance. Pediatric research is focusing on multiple alternative treatments targeting the main pathogenic factors such as insulin-resistance, dyslipidemia, gut-liver axis and microbiota, oxidative stress, and proinflammatory pathways. Results from these studies are promising but larger validation is needed. Innovative therapeutic approaches might add an important piece in the complex knowledge of pediatric NAFLD. We aimed to summarize recent insights into NAFLD diagnosis and treatment in children, with a focus on possible future perspectives in pediatric research.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:26Nephrotic Syndrome II : Assessment and Medical Management